Noninvasive identification of acute myocardial ischemia and reperfusion with contrast ultrasound using intravenous perfluoropropane-exposed sonicated dextrose albumin.

OBJECTIVES The purpose of this study was to determine whether intravenous dextrose albumin sonicated with a commonly used gas of low blood solubility and diffusivity (perfluoropropane) could identify acute myocardial ischemia and reperfusion. BACKGROUND Recently, it has been demonstrated that dextrose albumin sonicated with gases that have low blood solubility and diffusivity results in microbubbles capable of consistently producing myocardial ultrasound contrast after intravenous injection. It remains to be determined, however, whether this contrast agent can visually detect the myocardial blood flow abnormalities seen with acute ischemia or stunned myocardium after reperfusion. METHODS We gave intravenous injections (0.06 ml/kg body weight) of perfluoropropane-exposed sonicated dextrose albumin to 10 open chest dogs. The measured degree of myocardial contrast (0+ to 2+) and background-subtracted peak anterior myocardial videointensity produced from each injection were measured at three stages: 1) under baseline conditions, 2) during acute ischemia produced by a proximal left anterior descending coronary artery ligation lasting 10 to 120 min, and 3) after reflow was established. Coronary blood flow was monitored during all injections by using an ultrasound flow probe placed around the left anterior descending artery. RESULTS Coronary blood flow ranged from 0 to 137 ml/min, and peak myocardial videointensity after intravenous administration of perfluoropropane-exposed sonicated dextrose albumin ranged from 0 to 70 gray scale U. There was consistent visual myocardial opacification in all dogs during baseline conditions and a visually evident decrease in myocardial contrast in the left anterior descending artery distribution after ligation. A relative increase in contrast in this same distribution after intravenous contrast agent administration occurred in 7 of the 10 dogs during reflow. Quantitatively, there was an excellent correlation in individual dogs between peak myocardial videointensity and coronary flow at all stages (mean correlation coefficient 0.95 +/- 0.04, range 0.87 to 0.99). CONCLUSIONS Perfluoropropane-exposed sonicated dextrose albumin is an ultrasound contrast agent that can visually identify myocardial perfusion abnormalities from a peripheral venous injection.

[1]  S. Reisner,et al.  Evaluation of coronary flow reserve using myocardial contrast echocardiography in humans. , 1992, European heart journal.

[2]  S. Feinstein,et al.  Pitfalls in quantitative contrast echocardiography: the steps to quantitation of perfusion. , 1993, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[3]  Gusto Angiographic Investigators.  The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. , 1993, The New England journal of medicine.

[4]  K. Schwarz,et al.  Sonication of echo-contrast agents: a standardized and reproductible method , 1988 .

[5]  Sanjiv Kaul,et al.  Quantification of Myocardial Perfusion With Myocardial Contrast Echocardiography During Left Atrial Injection of Contrast: Implications for Venous Injection , 1994, Circulation.

[6]  A R Jayaweera,et al.  Myocardial contrast echocardiography and the transmural distribution of flow: a critical appraisal during myocardial ischemia not associated with infarction. , 1992, Journal of the American College of Cardiology.

[7]  T. Gardner,et al.  Current patterns of intraocular gas use in North America. , 1993, A M A Archives of Ophthalmology.

[8]  S. Kaul,et al.  Assessment of Risk Area During Coronary Occlusion and Infarct Size After Reperfusion With Myocardial Contrast Echocardiography Using Left and Right Atrial Injections of Contrast , 1993, Circulation.

[9]  G M Pohost,et al.  Contrast echocardiography in acute myocardial ischemia: I. In vivo determination of total left ventricular "area at risk". , 1984, Journal of the American College of Cardiology.

[10]  J B Newell,et al.  Contrast echocardiography in acute myocardial ischemia. III. An in vivo comparison of the extent of abnormal wall motion with the area at risk for necrosis. , 1986, Journal of the American College of Cardiology.

[11]  J. T. Thompson,et al.  Prediction of the kinetics of disappearance of sulfur hexafluoride and perfluoropropane intraocular gas bubbles. , 1988, Ophthalmology.

[12]  M. Quiñones,et al.  Assessment of regional myocardial perfusion with myocardial contrast echocardiography in a canine model of varying degrees of coronary stenosis. , 1994, American heart journal.

[13]  J R Shapiro,et al.  Myocardial perfusion imaging by contrast echocardiography with use of intracoronary sonicated albumin in humans. , 1989, Journal of the American College of Cardiology.

[14]  M. Fishbein,et al.  Early phase acute myocardial infarct size quantification: validation of the triphenyl tetrazolium chloride tissue enzyme staining technique. , 1981, American heart journal.

[15]  D D Watson,et al.  Assessment of Regional Myocardial Blood Flow with Myocardial Contrast Two-dimensional Echocardiography , 1989, Journal of the American College of Cardiology.

[16]  A. DeMaria,et al.  Myocardial washout of sonicated iopamidol reflects coronary blood flow in the absence of autoregulation. , 1992, Journal of the American College of Cardiology.

[17]  S. Kaul,et al.  Successful and Reproducible Myocardial Opacification During Two‐dimensional Echocardiography From Right Heart Injection of Contrast , 1992, Circulation.